Rates of pediatric diabetes diagnoses rose during the COVID-19 pandemic, driven primarily by an increase in type 2 diabetes cases among Hispanic youth and non-privately insured populations, Cureus reported. A retrospective hospital analysis revealed this upward shift occurred without a corresponding increase in diabetic ketoacidosis rates or severity.
The retrospective analysis examined youth aged zero to 18 years newly diagnosed with diabetes mellitus at a single, free-standing children’s hospital in Orlando, Florida. Researchers compared patients diagnosed prior to the public health crisis between September 2017 and March 2020 against those diagnosed during the pandemic period from March 2020 to September 2022. While overall pediatric diabetes incidence climbed, the data showed that only youth diagnosed with type 2 diabetes experienced a statistically significant increase during the pandemic window.
Socioeconomic Disparities Shape Rising Pediatric Diabetes Diagnoses
- Understanding the Diagnoses: Type 1 diabetes is an autoimmune condition where the body attacks insulin-producing cells, whereas type 2 diabetes involves insulin resistance linked to genetics and lifestyle factors.
- Tracking DKA: Diabetic ketoacidosis is a dangerous, life-threatening complication marked by high blood sugar and acidic blood that happens when the body lacks enough insulin.
- The Vulnerability Factor: Socioeconomically disadvantaged children and Hispanic youth bore the brunt of the rising diagnosis rates during the pandemic lockdowns.
Why Did Pediatric Diabetes Rates Shift During Pandemic Lockdowns?
Multiple variables contributed to the changing conditions of pediatric endocrine presentations between 2020 and 2022. Lockdowns and stay-at-home orders disrupted daily routines, eliminating in-person schooling, organized sports, and routine physical activity for children.
Simultaneously, viral factors played a biological role in altering glucose regulation. Scientific literature shows that viral infections can cause transient hyperglycemia through stress responses, impaired glucose clearance, and dysregulated insulin homeostasis. Laboratory studies demonstrate that the SARS-CoV-2 virus can directly infect pancreatic beta islet cells, potentially triggering or accelerating apoptotic pathways—programmed cell death—that introduce autoantigens to an already heightened immune system.
| Study Parameter | Pre-Pandemic Cohort | Pandemic Cohort |
|---|---|---|
| Timeline Range | September 2017 – March 2020 | March 2020 – September 2022 |
| Primary Setting | Single, Free-Standing Children’s Hospital (Orlando, Florida) | |
| Key Finding | Baseline Incidence | Significant Increase in Type 2 Diabetes and Vulnerable Youth |
How Did Socioeconomic Factors Influence Clinical Presentations?
The retrospective review uncovered distinct demographic disparities among newly diagnosed patients. Increases in diabetes diagnoses were notably concentrated among non-privately insured youth and children of Hispanic background. These groups faced disproportionate socioeconomic hardships and restricted healthcare accessibility while global healthcare systems strained under pandemic pressures.
Despite these barriers and fears surrounding infection risks that might have delayed routine care, the cohort did not exhibit a statistically significant rise in the rate or severity of diabetic ketoacidosis at diagnosis. Researchers utilized the 2018 International Society for Pediatric and Adolescent Diabetes guidelines to classify ketoacidosis severity based on venous pH and bicarbonate levels alongside hyperglycemic blood glucose readings exceeding 200 milligrams per deciliter. Recent international studies from regions like Australia and Saudi Arabia had illustrated an increase in the prevalence of T1D and severity of DKA presentation throughout the pandemic, making the Orlando findings a vital point of comparison for US healthcare systems.
What Lies Ahead for Pediatric Endocrine Research?
The findings were previously presented as meeting poster presentations at The Endocrine Society’s Annual Meeting on June 16, 2023, in Chicago, Illinois, and at the Pediatric Endocrine Society’s Annual Conference on May 3, 2024, also in Chicago. Investigators emphasize that further longitudinal research remains necessary to evaluate the long-term influence of the COVID-19 pandemic on pediatric diabetes incidence and clinical presentations.
References
- Thokalath A, Chalise S, Cooper F, et al. Rates of Diabetes Diagnoses and Diabetic Ketoacidosis Episodes Before Versus During the COVID-19 Pandemic. Cureus. 2026;18(11):e119131. doi:10.7759/cureus.119131
